P913: LOW-DOSE BELANTAMAB MAFODOTIN (BELAMAF) IN COMBINATION WITH NIROGACESTAT VS BELAMAF MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PHASE 1/2 DREAMM-5 PLATFORM SUB-STUDY 3

• Natalie Callander,
• Paul Richardson,
• Marek Hus,
• Vincent Ribrag,
• Joaquín Martinez-Lopez,
• Kihyun Kim,
• Jae Hoon Lee,
• Meletios A. Dimopoulos,
• Fredrik Schjesvold,
• Thierry Facon,
• Jae-Cheol Jo,
• Chang-Ki Min,
• Michał Mielnik,
• Shinta Cheng,
• Mary Smith,
• Caroline J. Breitbach,
• Chris Brawley,
• Harjeet Sembhi,
• John Lamacchia,
• Sebastian Grosicki

Affiliations

Natalie Callander

1 University of Wisconsin, Carbone Cancer Center, Madison, United States

Paul Richardson

2 Dana-Farber Cancer Institute, Boston, United States

Marek Hus

3 Katedra I Klinika Hematoonkologii I Transplantacji Szpiku, Lublin, Poland

Vincent Ribrag

4 Institute Gustave Roussy, Villejuif, France

Joaquín Martinez-Lopez

5 Department of Hematology, Hospital Universitario 12 de Octubre, Complutense University, CNIO, CIBERONC, Madrid, Spain

Kihyun Kim

6 Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Rep. of South

Jae Hoon Lee

7 Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Korea, Rep. of South

Meletios A. Dimopoulos

8 Alexandra Hospital, Athens, Greece

Fredrik Schjesvold

9 Oslo Myeloma Center, Department of Hematology, Oslo University Hosital and KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway

Thierry Facon

10 Department of Haematology, Lille University Hospital, Lille, France

Jae-Cheol Jo

11 Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea, Rep. of South

Chang-Ki Min

12 Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea, Rep. of South

Michał Mielnik

13 Katedra i Klinika Hematoonkologii i Transplantacji Szpiku, Lublin, Poland

Shinta Cheng

14 SpringWorks Therapeutics, Stamford, United States

Mary Smith

14 SpringWorks Therapeutics, Stamford, United States

Caroline J. Breitbach

14 SpringWorks Therapeutics, Stamford, United States

Chris Brawley

15 GSK, Stevenage, United Kingdom

Harjeet Sembhi

15 GSK, Stevenage, United Kingdom

John Lamacchia

16 GSK, Waltham, United States

Sebastian Grosicki

17 Department of Hematology and Cancer Prevention, Medical University of Silesia, Katowice, Poland